MARKET

GTH

GTH

Genetron Holdings Ltd
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.09
-1.16
-5.46%
After Hours: 20.49 +0.4 +1.99% 16:55 01/15 EST
OPEN
21.25
PREV CLOSE
21.25
HIGH
21.42
LOW
19.98
VOLUME
385.85K
TURNOVER
--
52 WEEK HIGH
21.75
52 WEEK LOW
9.03
MARKET CAP
1.78B
P/E (TTM)
-1.2873
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 14)
Benzinga · 2d ago
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 13)
Benzinga · 3d ago
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12)
Benzinga · 4d ago
Genetron Health to Present at BTIG Early Cancer Screening, Diagnostics Reimbursement and Genomic Tools KOL Day on Jan. 22, 2021
Business Wire · 4d ago
Company News for Jan 7, 2021
Zacks · 01/07 14:32
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 6)
Benzinga · 01/07 13:20
Company News for Jan 7, 2021
Zacks.com · 01/07 12:56
Genetron Health, Sino Biopharm's subsidiary inks strategic partnership for HCCscreen in China
Genetron Holdings (GTH) and Chia Tai Tianqing Pharmaceutical Group, a subsidiary of Sino Biopharmaceutical (SBHMY) and a leading liver drug franchise with a major presence in liver disease hospitals in China entered in
Seekingalpha · 01/06 11:05
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GTH. Analyze the recent business situations of Genetron Holdings Ltd through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average GTH stock price target is 20.02 with a high estimate of 21.09 and a low estimate of 19.00.
EPS
Institutional Holdings
Institutions: 53
Institutional Holdings: 17.30M
% Owned: 19.58%
Shares Outstanding: 88.36M
TypeInstitutionsShares
Increased
8
745.58K
New
26
-691.81K
Decreased
11
2.53M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About GTH
Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Genetron Holdings Ltd - ADR stock information, including NASDAQ:GTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GTH stock methods without spending real money on the virtual paper trading platform.